Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction

Synthetic Lethality Lethality
DOI: 10.1158/1078-0432.22472217.v1 Publication Date: 2023-04-01T14:36:52Z